News
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
While it is not the most common allergy in the country, almost 2 million Americans have an allergy to soy, according to Food ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
(Reuters) -Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the ...
(Reuters) -The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
The U.S. Food and Drug Administration said on Wednesday it has approved Nuvation Bio's drug for patients with a rare and ...
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...
The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...
3d
Medpage Today on MSNFDA Officials Lay Out Vision for AgencyThe new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results